Cardinal Health Inc. (NYSE:CAH) has received federal regulatory clearance to move ahead with its $1.3 billion purchase of New York-area drug distributor Kinray Inc. Cardinal expects to close the deal ...
NEW YORK (Reuters) - Drug wholesaler Cardinal Health Inc plans to buy privately held pharmaceutical distributor Kinray Inc for $1.3 billion to boost its presence in the northeastern United States.
Cardinal Health, a healthcare supply chain company, has been approved to close a proposed acquisition of Kinray, a pharmaceutical distributor serving in the New York metropolitan area, according to a ...